Immunohistochemical expression pattern of RIP5, FGFR1, FGFR2 and HIP2 in the normal human kidney development

Present study analyses the co-localisation of RIP5 with FGFR1, FGFR2 and HIP2 in the developing kidney, as RIP5 is a major determinant of urinary tract development, downstream of FGF-signaling. Paraffin embedded human kidney tissues of 16 conceptuses between the 6th-22th developmental week were anal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta histochemica 2019-07, Vol.121 (5), p.531-538
Hauptverfasser: Racetin, Anita, Raguž, Fila, Durdov, Merica Glavina, Kunac, Nenad, Saraga, Marijan, Sanna-Cherchi, Simone, Šoljić, Violeta, Martinović, Vlatka, Petričević, Joško, Kostić, Sandra, Mardešić, Snježana, Tomaš, Sandra Zekić, Kablar, Boris, Restović, Ivana, Lozić, Mirela, Filipović, Natalija, Saraga-Babić, Mirna, Vukojević, Katarina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 538
container_issue 5
container_start_page 531
container_title Acta histochemica
container_volume 121
creator Racetin, Anita
Raguž, Fila
Durdov, Merica Glavina
Kunac, Nenad
Saraga, Marijan
Sanna-Cherchi, Simone
Šoljić, Violeta
Martinović, Vlatka
Petričević, Joško
Kostić, Sandra
Mardešić, Snježana
Tomaš, Sandra Zekić
Kablar, Boris
Restović, Ivana
Lozić, Mirela
Filipović, Natalija
Saraga-Babić, Mirna
Vukojević, Katarina
description Present study analyses the co-localisation of RIP5 with FGFR1, FGFR2 and HIP2 in the developing kidney, as RIP5 is a major determinant of urinary tract development, downstream of FGF-signaling. Paraffin embedded human kidney tissues of 16 conceptuses between the 6th-22th developmental week were analysed using double-immunofluorescence method with RIP5/FGFR1/FGFR2 and HIP2 markers. Quantification of positive cells were performed using Kruskal–Wallis test. In the 6th week of kidney development RIP5 (89.6%) and HIP2 (39.6%) are strongly expressed in the metanephric mesenchyme. FGFR1 shows moderate/strong expression in the developing nephrons (87.3%) and collecting ducts (70.5%) (p 
doi_str_mv 10.1016/j.acthis.2019.04.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2229238071</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0065128119300297</els_id><sourcerecordid>2229238071</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-f65c11944b5d339d3110ebca668e34b27630d4414d61be4bf3f242252fb396ed3</originalsourceid><addsrcrecordid>eNp9kMFq3DAURUVpaaZJ_qAULbuIXT1J1tibQgmZZCDQENq1kKVnRlNbciU7JH8fB6dZdvU2597LO4R8BlYCA_XtWBo7HXwuOYOmZLJkAO_IBhTUBRNb_p5sGFNVAbyGE_Ip5yNjrGGCfyQnApjcqlpuSL8fhjnEpWeK9oCDt6an-DgmzNnHQEczTZgCjR29399VF3R3vbuH9XBqgqM3-ztOfaDTAWmIaVjyh3kwgf7xLuATdfiAfRwHDNMZ-dCZPuP56z0lv3dXvy5vituf1_vLH7eFFYpPRacqC9BI2VZOiMYJAIatNUrVKGTLt0owJyVIp6BF2Xai45LzinetaBQ6cUq-rr1jin9nzJMefLbY9yZgnLPmnDdc1GwLCypX1KaYc8JOj8kPJj1pYPrFsz7q1bN-8ayZ1IvnJfbldWFuB3RvoX9iF-D7CuDy54PHpLP1GCw6n9BO2kX__4VnWeCOvg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229238071</pqid></control><display><type>article</type><title>Immunohistochemical expression pattern of RIP5, FGFR1, FGFR2 and HIP2 in the normal human kidney development</title><source>Elsevier ScienceDirect Journals</source><creator>Racetin, Anita ; Raguž, Fila ; Durdov, Merica Glavina ; Kunac, Nenad ; Saraga, Marijan ; Sanna-Cherchi, Simone ; Šoljić, Violeta ; Martinović, Vlatka ; Petričević, Joško ; Kostić, Sandra ; Mardešić, Snježana ; Tomaš, Sandra Zekić ; Kablar, Boris ; Restović, Ivana ; Lozić, Mirela ; Filipović, Natalija ; Saraga-Babić, Mirna ; Vukojević, Katarina</creator><creatorcontrib>Racetin, Anita ; Raguž, Fila ; Durdov, Merica Glavina ; Kunac, Nenad ; Saraga, Marijan ; Sanna-Cherchi, Simone ; Šoljić, Violeta ; Martinović, Vlatka ; Petričević, Joško ; Kostić, Sandra ; Mardešić, Snježana ; Tomaš, Sandra Zekić ; Kablar, Boris ; Restović, Ivana ; Lozić, Mirela ; Filipović, Natalija ; Saraga-Babić, Mirna ; Vukojević, Katarina</creatorcontrib><description>Present study analyses the co-localisation of RIP5 with FGFR1, FGFR2 and HIP2 in the developing kidney, as RIP5 is a major determinant of urinary tract development, downstream of FGF-signaling. Paraffin embedded human kidney tissues of 16 conceptuses between the 6th-22th developmental week were analysed using double-immunofluorescence method with RIP5/FGFR1/FGFR2 and HIP2 markers. Quantification of positive cells were performed using Kruskal–Wallis test. In the 6th week of kidney development RIP5 (89.6%) and HIP2 (39.6%) are strongly expressed in the metanephric mesenchyme. FGFR1 shows moderate/strong expression in the developing nephrons (87.3%) and collecting ducts (70.5%) (p &lt; 0.05). RIP5/FGFR1 co-localized at the marginal zone and the ureteric bud with predominant FGFR1 expression. FGFR2 (26.1%) shows similar expression pattern as FGFR1 (70.5%) in the same kidney structures. RIP5/FGFR2 co-localized at the marginal zone and the collecting ducts (predominant expression of FGFR2). HIP2 is strongly expressed in collecting ducts (96.7%), and co-localized with RIP5. In 10th week, RIP5 expression decrease (74.2%), while the pattern of expression of RIP5 and FGFR1 in collecting ducts (33.4% and 91.9%) and developing nephrons (21.9% and 32.4%) (p &lt; 0.05) is similar to that in the 6th developmental week. Ureter is moderately expressing RIP5 while FGFR1 is strongly expressed in the ureteric wall. FGFR2 is strongly expressed in the collecting ducts (84.3%) and ureter. HIP2 have 81.1% positive cells in the collecting duct. RIP5/FGFR1 co-localize in collecting ducts and Henley’s loop. The expression pattern of RIP5, FGFR1, FGFR2 and HIP2 in the human kidney development might indicate their important roles in metanephric development and ureteric muscle layer differentiation through FGF signaling pathways.</description><identifier>ISSN: 0065-1281</identifier><identifier>EISSN: 1618-0372</identifier><identifier>DOI: 10.1016/j.acthis.2019.04.011</identifier><identifier>PMID: 31047684</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>FGFR1 ; FGFR2 ; Human embryo ; Kidney development ; RIP5</subject><ispartof>Acta histochemica, 2019-07, Vol.121 (5), p.531-538</ispartof><rights>2019 Elsevier GmbH</rights><rights>Copyright © 2019 Elsevier GmbH. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-f65c11944b5d339d3110ebca668e34b27630d4414d61be4bf3f242252fb396ed3</citedby><cites>FETCH-LOGICAL-c362t-f65c11944b5d339d3110ebca668e34b27630d4414d61be4bf3f242252fb396ed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0065128119300297$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31047684$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Racetin, Anita</creatorcontrib><creatorcontrib>Raguž, Fila</creatorcontrib><creatorcontrib>Durdov, Merica Glavina</creatorcontrib><creatorcontrib>Kunac, Nenad</creatorcontrib><creatorcontrib>Saraga, Marijan</creatorcontrib><creatorcontrib>Sanna-Cherchi, Simone</creatorcontrib><creatorcontrib>Šoljić, Violeta</creatorcontrib><creatorcontrib>Martinović, Vlatka</creatorcontrib><creatorcontrib>Petričević, Joško</creatorcontrib><creatorcontrib>Kostić, Sandra</creatorcontrib><creatorcontrib>Mardešić, Snježana</creatorcontrib><creatorcontrib>Tomaš, Sandra Zekić</creatorcontrib><creatorcontrib>Kablar, Boris</creatorcontrib><creatorcontrib>Restović, Ivana</creatorcontrib><creatorcontrib>Lozić, Mirela</creatorcontrib><creatorcontrib>Filipović, Natalija</creatorcontrib><creatorcontrib>Saraga-Babić, Mirna</creatorcontrib><creatorcontrib>Vukojević, Katarina</creatorcontrib><title>Immunohistochemical expression pattern of RIP5, FGFR1, FGFR2 and HIP2 in the normal human kidney development</title><title>Acta histochemica</title><addtitle>Acta Histochem</addtitle><description>Present study analyses the co-localisation of RIP5 with FGFR1, FGFR2 and HIP2 in the developing kidney, as RIP5 is a major determinant of urinary tract development, downstream of FGF-signaling. Paraffin embedded human kidney tissues of 16 conceptuses between the 6th-22th developmental week were analysed using double-immunofluorescence method with RIP5/FGFR1/FGFR2 and HIP2 markers. Quantification of positive cells were performed using Kruskal–Wallis test. In the 6th week of kidney development RIP5 (89.6%) and HIP2 (39.6%) are strongly expressed in the metanephric mesenchyme. FGFR1 shows moderate/strong expression in the developing nephrons (87.3%) and collecting ducts (70.5%) (p &lt; 0.05). RIP5/FGFR1 co-localized at the marginal zone and the ureteric bud with predominant FGFR1 expression. FGFR2 (26.1%) shows similar expression pattern as FGFR1 (70.5%) in the same kidney structures. RIP5/FGFR2 co-localized at the marginal zone and the collecting ducts (predominant expression of FGFR2). HIP2 is strongly expressed in collecting ducts (96.7%), and co-localized with RIP5. In 10th week, RIP5 expression decrease (74.2%), while the pattern of expression of RIP5 and FGFR1 in collecting ducts (33.4% and 91.9%) and developing nephrons (21.9% and 32.4%) (p &lt; 0.05) is similar to that in the 6th developmental week. Ureter is moderately expressing RIP5 while FGFR1 is strongly expressed in the ureteric wall. FGFR2 is strongly expressed in the collecting ducts (84.3%) and ureter. HIP2 have 81.1% positive cells in the collecting duct. RIP5/FGFR1 co-localize in collecting ducts and Henley’s loop. The expression pattern of RIP5, FGFR1, FGFR2 and HIP2 in the human kidney development might indicate their important roles in metanephric development and ureteric muscle layer differentiation through FGF signaling pathways.</description><subject>FGFR1</subject><subject>FGFR2</subject><subject>Human embryo</subject><subject>Kidney development</subject><subject>RIP5</subject><issn>0065-1281</issn><issn>1618-0372</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kMFq3DAURUVpaaZJ_qAULbuIXT1J1tibQgmZZCDQENq1kKVnRlNbciU7JH8fB6dZdvU2597LO4R8BlYCA_XtWBo7HXwuOYOmZLJkAO_IBhTUBRNb_p5sGFNVAbyGE_Ip5yNjrGGCfyQnApjcqlpuSL8fhjnEpWeK9oCDt6an-DgmzNnHQEczTZgCjR29399VF3R3vbuH9XBqgqM3-ztOfaDTAWmIaVjyh3kwgf7xLuATdfiAfRwHDNMZ-dCZPuP56z0lv3dXvy5vituf1_vLH7eFFYpPRacqC9BI2VZOiMYJAIatNUrVKGTLt0owJyVIp6BF2Xai45LzinetaBQ6cUq-rr1jin9nzJMefLbY9yZgnLPmnDdc1GwLCypX1KaYc8JOj8kPJj1pYPrFsz7q1bN-8ayZ1IvnJfbldWFuB3RvoX9iF-D7CuDy54PHpLP1GCw6n9BO2kX__4VnWeCOvg</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Racetin, Anita</creator><creator>Raguž, Fila</creator><creator>Durdov, Merica Glavina</creator><creator>Kunac, Nenad</creator><creator>Saraga, Marijan</creator><creator>Sanna-Cherchi, Simone</creator><creator>Šoljić, Violeta</creator><creator>Martinović, Vlatka</creator><creator>Petričević, Joško</creator><creator>Kostić, Sandra</creator><creator>Mardešić, Snježana</creator><creator>Tomaš, Sandra Zekić</creator><creator>Kablar, Boris</creator><creator>Restović, Ivana</creator><creator>Lozić, Mirela</creator><creator>Filipović, Natalija</creator><creator>Saraga-Babić, Mirna</creator><creator>Vukojević, Katarina</creator><general>Elsevier GmbH</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190701</creationdate><title>Immunohistochemical expression pattern of RIP5, FGFR1, FGFR2 and HIP2 in the normal human kidney development</title><author>Racetin, Anita ; Raguž, Fila ; Durdov, Merica Glavina ; Kunac, Nenad ; Saraga, Marijan ; Sanna-Cherchi, Simone ; Šoljić, Violeta ; Martinović, Vlatka ; Petričević, Joško ; Kostić, Sandra ; Mardešić, Snježana ; Tomaš, Sandra Zekić ; Kablar, Boris ; Restović, Ivana ; Lozić, Mirela ; Filipović, Natalija ; Saraga-Babić, Mirna ; Vukojević, Katarina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-f65c11944b5d339d3110ebca668e34b27630d4414d61be4bf3f242252fb396ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>FGFR1</topic><topic>FGFR2</topic><topic>Human embryo</topic><topic>Kidney development</topic><topic>RIP5</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Racetin, Anita</creatorcontrib><creatorcontrib>Raguž, Fila</creatorcontrib><creatorcontrib>Durdov, Merica Glavina</creatorcontrib><creatorcontrib>Kunac, Nenad</creatorcontrib><creatorcontrib>Saraga, Marijan</creatorcontrib><creatorcontrib>Sanna-Cherchi, Simone</creatorcontrib><creatorcontrib>Šoljić, Violeta</creatorcontrib><creatorcontrib>Martinović, Vlatka</creatorcontrib><creatorcontrib>Petričević, Joško</creatorcontrib><creatorcontrib>Kostić, Sandra</creatorcontrib><creatorcontrib>Mardešić, Snježana</creatorcontrib><creatorcontrib>Tomaš, Sandra Zekić</creatorcontrib><creatorcontrib>Kablar, Boris</creatorcontrib><creatorcontrib>Restović, Ivana</creatorcontrib><creatorcontrib>Lozić, Mirela</creatorcontrib><creatorcontrib>Filipović, Natalija</creatorcontrib><creatorcontrib>Saraga-Babić, Mirna</creatorcontrib><creatorcontrib>Vukojević, Katarina</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta histochemica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Racetin, Anita</au><au>Raguž, Fila</au><au>Durdov, Merica Glavina</au><au>Kunac, Nenad</au><au>Saraga, Marijan</au><au>Sanna-Cherchi, Simone</au><au>Šoljić, Violeta</au><au>Martinović, Vlatka</au><au>Petričević, Joško</au><au>Kostić, Sandra</au><au>Mardešić, Snježana</au><au>Tomaš, Sandra Zekić</au><au>Kablar, Boris</au><au>Restović, Ivana</au><au>Lozić, Mirela</au><au>Filipović, Natalija</au><au>Saraga-Babić, Mirna</au><au>Vukojević, Katarina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunohistochemical expression pattern of RIP5, FGFR1, FGFR2 and HIP2 in the normal human kidney development</atitle><jtitle>Acta histochemica</jtitle><addtitle>Acta Histochem</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>121</volume><issue>5</issue><spage>531</spage><epage>538</epage><pages>531-538</pages><issn>0065-1281</issn><eissn>1618-0372</eissn><abstract>Present study analyses the co-localisation of RIP5 with FGFR1, FGFR2 and HIP2 in the developing kidney, as RIP5 is a major determinant of urinary tract development, downstream of FGF-signaling. Paraffin embedded human kidney tissues of 16 conceptuses between the 6th-22th developmental week were analysed using double-immunofluorescence method with RIP5/FGFR1/FGFR2 and HIP2 markers. Quantification of positive cells were performed using Kruskal–Wallis test. In the 6th week of kidney development RIP5 (89.6%) and HIP2 (39.6%) are strongly expressed in the metanephric mesenchyme. FGFR1 shows moderate/strong expression in the developing nephrons (87.3%) and collecting ducts (70.5%) (p &lt; 0.05). RIP5/FGFR1 co-localized at the marginal zone and the ureteric bud with predominant FGFR1 expression. FGFR2 (26.1%) shows similar expression pattern as FGFR1 (70.5%) in the same kidney structures. RIP5/FGFR2 co-localized at the marginal zone and the collecting ducts (predominant expression of FGFR2). HIP2 is strongly expressed in collecting ducts (96.7%), and co-localized with RIP5. In 10th week, RIP5 expression decrease (74.2%), while the pattern of expression of RIP5 and FGFR1 in collecting ducts (33.4% and 91.9%) and developing nephrons (21.9% and 32.4%) (p &lt; 0.05) is similar to that in the 6th developmental week. Ureter is moderately expressing RIP5 while FGFR1 is strongly expressed in the ureteric wall. FGFR2 is strongly expressed in the collecting ducts (84.3%) and ureter. HIP2 have 81.1% positive cells in the collecting duct. RIP5/FGFR1 co-localize in collecting ducts and Henley’s loop. The expression pattern of RIP5, FGFR1, FGFR2 and HIP2 in the human kidney development might indicate their important roles in metanephric development and ureteric muscle layer differentiation through FGF signaling pathways.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>31047684</pmid><doi>10.1016/j.acthis.2019.04.011</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0065-1281
ispartof Acta histochemica, 2019-07, Vol.121 (5), p.531-538
issn 0065-1281
1618-0372
language eng
recordid cdi_proquest_miscellaneous_2229238071
source Elsevier ScienceDirect Journals
subjects FGFR1
FGFR2
Human embryo
Kidney development
RIP5
title Immunohistochemical expression pattern of RIP5, FGFR1, FGFR2 and HIP2 in the normal human kidney development
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T18%3A09%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunohistochemical%20expression%20pattern%20of%20RIP5,%20FGFR1,%20FGFR2%20and%20HIP2%20in%20the%20normal%20human%20kidney%20development&rft.jtitle=Acta%20histochemica&rft.au=Racetin,%20Anita&rft.date=2019-07-01&rft.volume=121&rft.issue=5&rft.spage=531&rft.epage=538&rft.pages=531-538&rft.issn=0065-1281&rft.eissn=1618-0372&rft_id=info:doi/10.1016/j.acthis.2019.04.011&rft_dat=%3Cproquest_cross%3E2229238071%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2229238071&rft_id=info:pmid/31047684&rft_els_id=S0065128119300297&rfr_iscdi=true